代谢组学技术在慢性阻塞性肺疾病研究中的运用
The Application of Metabolomics Technology in the Study of Chronic Obstructive Pulmonary Disease
摘要: 慢性阻塞性肺疾病(COPD)是一种慢性呼吸道的异质性疾病,与心血管疾病、代谢综合症等多系统疾病发生发展密切相关,严重影响患者生活质量,同时给患者的家庭和社会带来了巨大的经济负担。目前COPD发病机制尚未完全阐明,而且诊断和治疗手段有限。近些年,代谢组学的兴起为该病提供了新的方法手段。因此,代谢组学是对小分子代谢物及其产生过程中的分支的研究,当机体处于病理生理状态时,可以检测到生物途径的细微变化,反映有机体的当前代谢状态,深入了解各种生理条件和异常过程的机制。本文介绍了代谢组学,通过揭示氨基酸、脂质在COPD中的病理生理机制以及从血液、呼吸、组织代谢组学三方面阐述了基于代谢组学技术在COPD研究中的运用,为复杂的呼吸系统疾病研究提供了技术手段,有益于进一步明确COPD发病及其进展的机制。
Abstract: Chronic obstructive pulmonary disease (COPD) is a chronic respiratory heterogeneous disease, which is closely related to the development of multiple system diseases such as cardiovascular dis-ease and metabolic syndrome, and seriously influences the quality of life of patients, while causing a huge economic burden to the patients’ families and society back. The pathogenesis of COPD is not yet fully elucidated, and the diagnostic and therapeutic tools are limited. In recent years, the rise of metabolomics has provided new methodological tools for this disease. Therefore, metabolomics is the study of small molecule metabolites and their branches in the production process, and when the organism is in a pathophysiological state, it can detect subtle changes in biological pathways, reflect the current metabolic state of the organism, and provide insight into the mechanisms of various physiological conditions and abnormal processes. In this paper, metabolomics is introduced, and the use of metabolomics-based technologies in COPD research is described by revealing the patho-physiological mechanisms of amino acids and lipids in COPD as well as from the three aspects of blood, respiratory and tissue metabolomics, which provide technical means for the study of complex respiratory diseases, and are useful for further clarifying the mechanisms of COPD pathogenesis and its progression.
文章引用:冯歆维. 代谢组学技术在慢性阻塞性肺疾病研究中的运用[J]. 临床医学进展, 2023, 13(8): 13381-13387. https://doi.org/10.12677/ACM.2023.1381870

参考文献

[1] Venkatesan, P. (2023) GOLD COPD Report: 2023 Update. The Lancet Respiratory Medicine, 11, 18. [Google Scholar] [CrossRef
[2] Alderawi, A., Caramori, G., Baker, E.H., et al. (2020) FN3K Expression in COPD: A Potential Comorbidity Factor for Cardiovascular Disease. BMJ Open Respiratory Research, 7, e000714. [Google Scholar] [CrossRef] [PubMed]
[3] Regan, E.A., Hersh, C.P., Castaldi, P.J., et al. (2019) Omics and the Search for Blood Biomarkers in Chronic Obstructive Pulmonary Disease: Insights from COPD Gene. American Journal of Respiratory Cell and Molecular Biology, 61, 143-149. [Google Scholar] [CrossRef
[4] Labaki, W.W. and Rosenberg, S.R. (2020) Chronic Obstructive Pulmonary Disease. Annals of Internal Medicine, 173, ITC17-ITC32. [Google Scholar] [CrossRef
[5] 何响, 孙泽蕊, 石雪峰. 肺表面活性蛋白D与慢性阻塞性肺疾病关系的研究进展[J]. 实用心脑肺血管病杂志, 2022, 30(9): 127-131.
[6] Huang, Q., Wu, X., Gu, Y., et al. (2022) Detection of the Disorders of Glycerophospholip-ids and Amino Acids Metabolism in Lung Tissue from Male COPD Patients. Frontiers in Molecular Biosciences, 9, Ar-ticle ID: 839259. [Google Scholar] [CrossRef] [PubMed]
[7] Gea, J., Enriquez-rodriguez, C.J. and Pascual-guardia, S. (2023) Metabolomics in COPD. Archivos de Bronconeumología, 59, 311-321. [Google Scholar] [CrossRef] [PubMed]
[8] Pulik, K., Mycroft, K., Korczynski, P., et al. (2023) Metabolomic Analysis of Respiratory Epithelial Lining Fluid in Patients with Chronic Obstructive Pulmonary Disease—A Systematic Review. Cells, 12, Article No. 833. [Google Scholar] [CrossRef] [PubMed]
[9] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版) [J]. 中华结核和呼吸杂志, 2021, 44(3): 36.
[10] Pinson, M.R., Deutz, N., Harrykissoon, R., et al. (2021) Disturbances in Branched-Chain Amino Acid Profile and Poor Daily Functioning in Mildly Depressed Chronic Obstructive Pulmonary Disease Patients. BMC Pulmonary Medicine, 21, Article No. 351. [Google Scholar] [CrossRef] [PubMed]
[11] Wang, Y., Li, P., Cao, Y., et al. (2023) Skeletal Muscle Mitochondrial Dysfunction in Chronic Obstructive Pulmonary Disease: Underly-ing Mechanisms and Physical Therapy Perspectives. Aging and Disease, 14, 33-45. [Google Scholar] [CrossRef
[12] Arezina, R., Chen, T. and Wang, D. (2023) Conventional, Comple-mentary and Alternative Medicines: Mechanistic Insights into Therapeutic Landscape of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease, 18, 447-457. [Google Scholar] [CrossRef
[13] Ran, N., Pang, Z., Gu, Y., et al. (2019) An Updated Overview of Metabolomic Profile Changes in Chronic Obstructive Pulmonary Disease. Metabolites, 9, 111. [Google Scholar] [CrossRef] [PubMed]
[14] Mangoni, A.A., Rodionov, R.N., Mcevoy, M., et al. (2019) New Ho-rizons in Arginine Metabolism, Ageing and Chronic Disease States. Age Ageing, 48, 776-782. [Google Scholar] [CrossRef] [PubMed]
[15] Zhou, B., Jiang, G.T., Liu, H., et al. (2021) Dysregulated Arginine Me-tabolism in Young Patients with Chronic Persistent Asthma and in Human Bronchial Epithelial Cells. Nutrients, 13, Arti-cle No. 4116. [Google Scholar] [CrossRef] [PubMed]
[16] Vogeli, A., Ottiger, M., Meier, M.A., et al. (2017) Asymmetric Dime-thylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Dis-ease. Lung, 195, 717-727. [Google Scholar] [CrossRef] [PubMed]
[17] Maneechotesuwan, K., Wongkajornsilp, A., Adcock, I.M., et al. (2015) Simvastatin Suppresses Airway IL-17 and Upregulates IL-10 in Patients with Stable COPD. Chest, 148, 1164-1176. [Google Scholar] [CrossRef] [PubMed]
[18] Arshad, H., Siokis, A., Franke, R., et al. (2022) Repro-gramming of Amino Acid Metabolism Differs between Community-Acquired Pneumonia and Infection-Associated Ex-acerbation of Chronic Obstructive Pulmonary Disease. Cells, 11, Article No. 2283. [Google Scholar] [CrossRef] [PubMed]
[19] Kotlyarova, A. (2021) Anti-Inflammatory Function of Fatty Acids and Involvement of Their Metabolites in the Resolution of Inflammation in Chronic Obstructive Pulmonary Disease. Interna-tional Journal of Molecular Sciences, 22, Article No. 12803. [Google Scholar] [CrossRef] [PubMed]
[20] Celejewska-wojcik, N., Kania, A., Gorka, K., et al. (2021) Eicosanoids and Eosinophilic Inflammation of Airways in Stable COPD. International Journal of Chronic Obstructive Pulmonary Disease, 16, 1415-1424. [Google Scholar] [CrossRef
[21] Chen, H., Li, Z., Dong, L., et al. (2019) Lipid Metabolism in Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease, 14, 1009-1018. [Google Scholar] [CrossRef
[22] Siskind, L.J., Kolesnick, R.N. and Colombini, M. (2006) Ceramide Forms Channels in Mitochondrial Outer Membranes at Physiologically Relevant Concentrations. Mitochondrion, 6, 118-125. [Google Scholar] [CrossRef] [PubMed]
[23] Bodas, M., Pehote, G., Silverberg, D., et al. (2019) Autophagy Augmentation Alleviates Cigarette Smoke-Induced CFTR-Dysfunction, Ceramide-Accumulation and COPD-Emphysema Pathogenesis. Free Radical Biology and Medicine, 131, 81-97. [Google Scholar] [CrossRef] [PubMed]
[24] Kim, H.Y., Lee, H.S., Kim, I.H., et al. (2022) Compre-hensive Targeted Metabolomic Study in the Lung, Plasma, and Urine of PPE/LPS-Induced COPD Mice Model. Interna-tional Journal of Molecular Sciences, 23, Article No. 2748. [Google Scholar] [CrossRef] [PubMed]
[25] PintoI-plata, V., Casanova, C., Divo, M., et al. (2019) Plasma Metabo-lomics and Clinical Predictors of Survival Differences in COPD Patients. Respiratory Research, 20, Article No. 219. [Google Scholar] [CrossRef] [PubMed]
[26] Nambiar, S., Tan, D., Clynick, B., et al. (2021) Untargeted Metabolomics of Human Plasma Reveal Lipid Markers Unique to Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis. Proteomics: Clinical Applications, 15, e2000039. [Google Scholar] [CrossRef] [PubMed]
[27] Gai, X., Guo, C., Zhang, L., et al. (2021) Serum Glycerophospholipid Profile in Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Frontiers in Physiology, 12, Article ID: 646010. [Google Scholar] [CrossRef] [PubMed]
[28] Kim, D.J., Oh, J.Y., Rhee, C.K., et al. (2021) Metabolic Finger-printing Uncovers the Distinction between the Phenotypes of Tuberculosis Associated COPD and Smoking-Induced COPD. Frontiers in Medicine (Lausanne), 8, Article ID: 619077. [Google Scholar] [CrossRef] [PubMed]
[29] Cai, C., Bian, X., Xue, M., et al. (2019) Eicosanoids Metabolized through LOX Distinguish Asthma-COPD Overlap from COPD by Metabolomics Study. International Journal of Chronic Obstructive Pulmonary Disease, 14, 1769-1778. [Google Scholar] [CrossRef
[30] Maniscalco, M., Paris, D., Melck, D.J., et al. (2018) Differential Di-agnosis between Newly Diagnosed Asthma and COPD Using Exhaled Breath Condensate Metabolomics: A Pilot Study. European Respiratory Journal, 51, Article ID: 1701825. [Google Scholar] [CrossRef] [PubMed]
[31] Maniscalco, M., Paris, D., Cuomo, P., et al. (2022) Metabo-lomics of COPD Pulmonary Rehabilitation Outcomes via Exhaled Breath Condensate. Cells, 11, Article No. 344. [Google Scholar] [CrossRef] [PubMed]
[32] Halper-stromberg, E., Gillenwater, L., Cruickshank-quinn, C., et al. (2019) Bronchoalveolar Lavage Fluid from COPD Patients Reveals More Compounds Associated with Disease than Matched Plasma. Metabolites, 9, Article No. 157. [Google Scholar] [CrossRef] [PubMed]
[33] Madapoosi, S.S., Cruickshank-quinn, C., Opron, K., et al. (2022) Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 206, 427-439. [Google Scholar] [CrossRef
[34] 吕田田, 余亚辉, 余海艳, 等. 慢性阻塞性肺病稳定期模型大鼠支气管肺泡灌洗液的代谢组学研究[J]. 中国医院药学杂志, 2021, 41(19): 1955-1961.
[35] Zhu, T., Li, S., Wang, J., et al. (2020) Induced Sputum Metabolomic Profiles and Oxidative Stress Are Associated with Chronic Ob-structive Pulmonary Disease (COPD) Severity: Potential Use for Predictive, Preventive, and Personalized Medicine. EPMA Journal, 11, 645-659. [Google Scholar] [CrossRef] [PubMed]
[36] Esther, C.J., O’neal, W.K., An-derson, W.H., et al. (2022) Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD. Chest, 161, 1239-1249.
[37] Liu, S.J., Ma, Y.L., Fang, F., et al. (2021) Metabonomics Research on Lung Tissue of Rats with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Treated with Mineral Chinese Medicine Chloriti Lapis. China Journal of Chinese Materia Medica, 46, 3133-3143.